Enabling Faster Therapeutic Antibody Discovery Through AI/ML-Wet Lab Integration

Explore an innovative AI/ML platform that guides antibody design and accelerates the discovery of better antibody therapeutics in this 33-minute webinar. Learn how BigHat Biosciences integrates high-speed wet lab techniques with artificial intelligence and machine learning to create superior antibodies faster. Discover the potential of synthetic biology in developing safer and more effective antibody therapies for patients. Gain insights into the Milliner platform, which enables dynamic tracking and monitoring of laboratory and data generation processes. Understand how BigHat's automation strategy prioritizes early and flexible development, utilizing a cutting-edge technology stack. Examine the multi-tiered control systems that allow for close monitoring and optimization of the platform, extending to lab operations and documentation. Delve into the world of human-designed, next-generation antibodies and their potential as breakthrough therapeutics.